wsjhealth

Could Scientist Find Drug to Treat His Own Disease?

How a researcher’s 12-year journey to a new Bristol-Myers psoriasis medicine became personal: “You have hopes and daydreams almost in…

2 years ago

Hospitals Shutter Maternity Wards Amid Falling Birthrates

Women have fewer delivery options in rural, aging parts of the U.S. Source link

2 years ago

Weight-Loss Drug Wegovy Cuts Heart Risk in New Study

Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link

2 years ago

Drug Shortages Are a Boon to One Industry: Compounding Pharmacies

Hospitals increasingly rely on a sector that can start making drugs without FDA approval—and investment is pouring in. Source link

2 years ago

Pfizer’s Covid Boost Crashes to Earth

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber…

2 years ago

First Pill for Postpartum Depression Is Approved by FDA

The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a…

2 years ago

The Political Turf Battle Over the Future of Your Prime Rib

The White House must decide whether the Food and Drug Administration or Agriculture Department will oversee the food-company scientists tweaking…

2 years ago

Employers Cut Off Access to Weight-Loss Drugs for Workers

Costs are mounting for popular drugs such as Wegovy, a cousin of Ozempic, and healthcare plans are restricting coverage to…

2 years ago

Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease Shortfall

The company is rolling out 19 products or new uses within 18 months, CEO Albert Bourla said. Source link

2 years ago

Biogen to Buy Reata in $7.3 Billion Deal

The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases. Source link

2 years ago